Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Prostate Cancer

Free Subscription 28.09.2026 1 AJR Am J Roentgenol 1 BJU Int 1 Cancer Res 2 Eur Urol 1 Int J Cancer 1 Int J Radiat Oncol Biol Phys 1 Int J Urol 3 J Nucl Med 1 J Urol 1 Proc Natl Acad Sci U S A 1 Prostate

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. JOO Y, Tse JR, Yoon J, Jung DC, et al
   Upfront Biparametric MRI for Prostate Cancer Screening: Experience in 618 Korean Men Outside of a Clinical Trial Setting.
   AJR Am J Roentgenol. 2026 Sep 23. doi: 10.2214/AJR.26.35694.
   PubMed         Abstract available
   
   

   
   BJU Int

2. 
   Correction to "Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)".
   BJU Int. 2026 Sep 22. doi: 10.1111/bju.70466.
   PubMed        
   
   

   
   Cancer Res

3. ZHOU L, Murphy KC, Giwa HK, Hu K, et al
   Senolytic Interventions Enhance the Anti-metastatic Activity of Chemotherapy in Prostate Cancer.
   Cancer Res. 2026 Sep 21. doi: 10.1158/0008-5472.CAN-26-0493.
   PubMed         Abstract available
   
   

   
   Eur Urol

4. BRATT O, Lantz A, Godtman RA
   Re: Agne Krilaviciute, Nikolaus Becker, Sigrid V. Carlsson, et al. Confirmation of Prostate-specific Antigen (PSA) Values Improves Prostate Cancer Screening in Early Middle-aged Men - Data from the PROBASE Trial. Eur Urol. In press. https://doi.org/10
   Eur Urol. 2026 Sep 25:S0302-2838(26)02373-0. doi: 10.1016/j.eururo.2026.
   PubMed        
   
   
5. BERGMAN DT, Nagar H, McClure TD
   Re: Alexander Light, Max Peters, Archana Gopalakrishnan, et al. Oncological Outcomes Following Focal HIFU and Cryotherapy for Treatment of Nonmetastatic Prostate Cancer in the United Kingdom: An Updated Analysis of 3477 Patients from the Prospective H
   Eur Urol. 2026 Sep 23:S0302-2838(26)02375-4. doi: 10.1016/j.eururo.2026.
   PubMed        
   
   

   
   Int J Cancer

6. BOSETTI C, Visser O, Van Eycken L, Pettersson D, et al
   Availability of Stage Information From Cancer Registries Providing Data to the European Cancer Information System for Six Selected Cancers.
   Int J Cancer. 2026;159:2540-2551.
   PubMed         Abstract available
   
   

   
   Int J Radiat Oncol Biol Phys

7. KOOPMANS PJ, Monshouwer R, Findhammer J, Smeenk RJ, et al
   Temporal Analysis of Prostate Magnetic Resonance Linac Data.
   Int J Radiat Oncol Biol Phys. 2026;126:856-867.
   PubMed         Abstract available
   
   

   
   Int J Urol

8. MIYAJIMA K, Yanagisawa T, Fukuokaya W, Sakakibara R, et al
   Prognostic Stratification in High-Volume Metastatic Hormone-Sensitive Prostate Cancer Treated With First-Line Androgen Receptor Pathway Inhibitor-Based Combination Therapy.
   Int J Urol. 2026;33:e70646.
   PubMed         Abstract available
   
   

   
   J Nucl Med

9. SHEHERYAR N, Nikanpour Y, Manohar S, Childs D, et al
   Renal Function Decline After (177)Lu-PSMA-617 Versus Taxane-Based Chemotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Propensity Score Analysis.
   J Nucl Med. 2026 Sep 24:jnumed.126.272551. doi: 10.2967/jnumed.126.272551.
   PubMed         Abstract available
   
   
10. MAHAJAN V, Yu L, Kollitz L, Boytim E, et al
    Association of ATM Alterations with Outcomes After (177)Lu-PSMA-617 Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer.
    J Nucl Med. 2026 Sep 24:jnumed.126.273055. doi: 10.2967/jnumed.126.273055.
    PubMed         Abstract available
    
    
11. ZHAO R, Li M, Lv J, Zhang J, et al
    Phase 1 Dose-Escalation Study of the Rapid-Clearance Radioligand [(177)Lu]Lu-P17-087 in Metastatic Castration-Resistant Prostate Cancer: Dosimetry, Safety, and Preliminary Efficacy.
    J Nucl Med. 2026 Sep 24:jnumed.126.272406. doi: 10.2967/jnumed.126.272406.
    PubMed         Abstract available
    
    

    
    J Urol

12. TOSOIAN JJ, Meyers JI, Chinnaiyan AM
    Reply: Non-Invasive Urine Test Predicts Grade Group Upgrading in Patients on Active Surveillance for Prostate Cancer: Prospective Multisite Validation and Comparison with MRI.
    J Urol. 2026 Sep 22:101097JU0000000000005299. doi: 10.1097/JU.0000000000005299.
    PubMed        
    
    

    
    Proc Natl Acad Sci U S A

13. SHI X, Fan Z, Qu M, Lin C, et al
    Follistatin drives AR-independent prostate cancer through BMP signaling inactivation and microenvironmental remodeling.
    Proc Natl Acad Sci U S A. 2026;123:e2603564123.
    PubMed         Abstract available
    
    

    
    Prostate

14. PAN Z, Fan J, Zhang L, Zhao R, et al
    Cross-Cohort Characterization of an LHB-Associated Transcriptomic State in Prostate Cancer.
    Prostate. 2026 Sep 19. doi: 10.1002/pros.70256.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum